(a) 'Insertional inactivation' is a method to detect recombinant DNA. Explain the method.

or

(b) Explain how recombinant DNA technology is used to detect a disease even before any clinical symptom appears.

This question contains two options, (a) and (b). Let us explain both step-by-step.

Part (a): Explanation of 'Insertional Inactivation'

Insertional inactivation is a powerful selection method used in recombinant DNA technology to differentiate between recombinant and non-recombinant bacteria based on their ability to produce an active enzyme. The process works as follows:
1. Insertion of Gene: The recombinant DNA (the foreign gene of interest) is inserted directly into the coding sequence of the gene that synthesizes the enzyme β-galactosidase.
2. Inactivation of the Enzyme Gene: Because the foreign DNA disrupts the sequence of the gene, the gene becomes inactive and can no longer produce functional β-galactosidase. This is called insertional inactivation.
3. Role of the Chromogenic Substrate: The bacteria are grown on a medium containing a chromogenic (color-producing) substrate.
4. Observation:
• Non-recombinants: If the plasmid inside the bacteria does not contain the foreign insert, the β-galactosidase gene remains intact and active. The enzyme hydrolyzes the substrate, yielding blue-colored colonies.
• Recombinants: If the plasmid contains the foreign insert, the gene is inactivated, and no active β-galactosidase is synthesized. As a result, these colonies do not produce any color (they remain white/colorless).

Part (b): Detecting Disease Before Clinical Symptoms Appear

Recombinant DNA technology provides highly sensitive techniques to detect pathogens or genetic mutations at an early stage, even when their concentration is extremely low and clinical symptoms have not yet manifested. Two primary methods are used:

Method 1: Molecular Probes and Autoradiography
1. Preparation of Probe: A single-stranded DNA or RNA molecule is synthesized and tagged with a radioactive molecule. This is called a probe.
2. Hybridization: The probe is allowed to hybridize (bind) with its complementary DNA sequence in a clone of host cells.
3. Detection: The cells are then analyzed using autoradiography.
4. Result: Because the probe is complementary to the normal/non-mutated gene, it will bind to it. The clone containing the mutated gene will not hybridize with the probe, and therefore, it will not appear on the photographic film. This allows identification of the mutated gene.

Method 2: Polymerase Chain Reaction (PCR)
1. Concept: PCR is used to amplify extremely small amounts of pathogen DNA or RNA to detectable levels.
2. Process: It involves cycles of denaturation (separating DNA strands), annealing (binding pathogen-specific primers to the target sequence), and extension to exponentially amplify the DNA.
3. Result: By detecting this amplified genetic material, clinicians can identify the presence of a pathogen before the body starts showing clinical symptoms of the disease.